Beijing SL Pharmaceutical (002038.SZ) joint venture company Xuanzhu Biosciences is expected to be listed on the Hong Kong Stock Exchange on October 15th.

Beijing SL Pharmaceutical (002038.SZ) announced that its affiliated company, Xuanzhu Biotech (02575), is expected to officially list on the Hong Kong Stock Exchange on October 15, 2025. According to the global prospectus disclosed by Xuanzhu Biotech, the company will issue 67.3335 million shares at a price of HK$11.60 per share. Beijing SL Pharmaceutical holds a total of 1.7808 million shares, which is expected to account for 0.34% of the total number of shares issued after the listing. The lock-up period for Xuanzhu Jinyu Bio-Technology held by the company is 12 months after Xuanzhu Biotech's listing.